*Dr. Udoh Andikan Effiong, Krystal Amoroso, Bishar Musse, Tesfatsiyon Mammo Ergando, Marium Faiz, Naglaa Ghobriel, Andrés Alberto Figueroa Quast, Mohammed Adnan Sheerazi, Suveenkrishna Pothuru, Saud Al-ezzi, Sujan Poudel and Shakir Al-ezzi


The pandemic of the coronavirus disease-19 (COVID-19), the causative agent of the severe acute respiratory syndrome-2 (SARS-CoV-2), has become a public health emergency of the international concern. The majority of the population is exhibiting signs and symptoms similar to the flu and common cold. Despite that, alveolar damage result in progressive lung failure has also been reported. Although COVID-19 has been reported principally to affect the respiratory system, other system‟s involvement has also been reported. Renal involvement has also been underlined in the literature. Renal involvement in SARS-COV-2 usually corresponds to three situations: (a) renal manifestation of acute kidney injury, (b) renal manifestation of chronic kidney injury, (c) renal manifestation in patients with a kidney transplant, and the patients on dialysis. The actual disease pathogenesis is unknown; however, direct viral injury, inflammation due to markers, activation of the complement system, and coagulation cascades might be the cause. Patients with renal involvement usually experience a wide range of signs and symptoms such as oliguria, anuria, proteinuria, hematuria, lower abdominal and back pain, or elevation in creatinine and blood urea nitrogen. The pandemic of SARS-CoV-2 has become a unique challenge for the nephrologist. Various renal manifestations have been observed and reported in many cases, and even renal features may precede the classical respiratory signs and symptoms. In this review, we have summarized the information from published literature including, case reports and open-source data sets, to describe the spectrum of renal manifestation and complication observed in COVID-19 cases.

Keywords: .

[Full Text Article]


Forgot Password  |  Register


Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation


    FEBRUARY 2023 Issue has been successfully launched on 1 FEBRUARY 2023.

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.


UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS


Copyright From

Covering Letter

                        Author Instruction